Health Benefits Hub

March 20, 2019

What’s coming for private plans from Canada’s drug pipeline

More than 140 drugs are braced for launch from Canada’s drug pipeline today, as they await regulatory approval from Health Canada. The TELUS Health Drug Pipeline Report takes a closer look at 14 of these drugs, anticipated to have the most impact on private drug plans and also take a […]

Stay Informed

All the latest articles delivered directly to your inbox.

Sign up

We will use your email address to send you our newsletter.
All communications will be from TELUS Health.

All fields are required

First name

Last name

Language

Company Name

Job title

Select the option that best describes your role

We will use your email address to send you our newsletter. All communications will be coming from TELUS Health. Our contact information is: 630 René-Lévesque Blvd. West, 22nd floor, Montreal, QC J4K 5B1. Email: telushealth@telus.com. Phone: 1-877-999-4669. We assure you that your email address will not be shared with any third party. You can withdraw your consent to receive electronic messages from TELUS Health at any time.

December 17, 2018

Insights on the private payer industry

What’s coming for private plans from Canada’s drug pipeline

The war on lives: a look inside the opioid crisis

Building a highway to wellness with virtual care

Practical considerations for coverage of medical cannabis